Status:
UNKNOWN
Treatment of Patients With Optic Nerve Damage Patients Using Electrostimulation
Lead Sponsor:
University of Magdeburg
Conditions:
Glaucoma
Electrical Stimulation
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of the present study is to investigate the possibilities of visual field enhancement with electrical stimulation (ES) as a home stimulation method, in a total of 50 patients with optical neuro...
Eligibility Criteria
Inclusion
- Patients with glaucoma, disease duration at least 6 months
- stable visual field defect across baseline measurement (subjects with spontaneous fluctuations and recovery of vision excluded)
- presence of residual vision and detectable gradual transition between the intact and the absolutely blind part of the visual field according to evaluation of the clinician
- best corrected visual acuity at least 0.4 (20/50 Snellen) or better
Exclusion
- autoimmune diseases in the acute stage
- neurological and mental diseases
- diabetic retinopathy
- addictions
- hypertension (maximum 160/100 mmHg)
- retinitis pigmentosa-
- pathological nystagmus
- non-distant tumors or recurrent tumors
- photosensitivity
- pregnancy
- electric or electronic implants (e.g. heart pacemaker)
- metal implants in the eyes or head (with the exception of dental prosthesis or shunts)
Key Trial Info
Start Date :
August 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04010994
Start Date
August 5 2019
End Date
December 31 2020
Last Update
October 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Medical Psychology
Magdeburg, Germany, 39120